11 Results for "

Liraglutide

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "Liraglutide" in MCE Product Catalog:

42
42 Publications Verification
Cat. No.: HY-P0014
CAS No.: 204656-20-2
Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus.
loading...
    loading...
42
42 Publications Verification
Cat. No.: HY-P0014B
Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

Liraglutide (TFA) is an agonist of glucagon-like peptide 1 receptor (GLP-1). Liraglutide (TFA) can activate GLP-1, leading to the release of insulin in the presence of increased glucose concentration. Liraglutide (TFA) also reduces glucagon secretion in a glucose-dependent manner. Liraglutide (TFA) can be studied in research on type 2 diabetes .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-108022A
CAS No.: 1314533-27-1
Purity:  99.53%
Synonyms: MSDC-0602K
Target:  

Insulin Receptor PPAR

Research Areas:  

Metabolic Disease

Azemiglitazone potassium (MSDC-0602K), a PPARγ-sparing thiazolidinedione (Ps-TZD), binds to PPARγ with the IC50 of 18.25 μM . Azemiglitazone potassium modulates the mitochondrial pyruvate carrier (MPC). Azemiglitazone potassium can be used for the research of fatty liver including dysfunctional lipid metabolism, inflammation, and insulin resistance . Azemiglitazone potassium, an insulin sensitizer, improves insulinemia and fatty liver disease in mice, alone and in combination with Liraglutide .
loading...
    loading...
Cat. No.: HY-P0014S1
Research Areas:  

Others

Liraglutide- 13C6, 15 tetraTFA is the 13C and 15N labeled Liraglutide (HY-P0014) . Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the study of type 2 diabetes mellitus .
loading...
    loading...
Cat. No.: HY-139276
CAS No.: 294855-91-7
Target:  

GLP Receptor

Research Areas:  

Others

Pal-Glu(OSu)-OH is a side chain of Liraglutide. Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used for type 2 diabetes mellitus research .
loading...
    loading...
Cat. No.: HY-P0014AS
Research Areas:  

Metabolic Disease

Liraglutide-d8 tetraTFA is deuterium labeled Liraglutide (HY-P0014). Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the study of type 2 diabetes mellitus .
loading...
    loading...
Cat. No.: HY-P0014A
CAS No.: 1997361-86-0
Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

Liraglutide acetate is the acetate form of Liraglutide (HY-P0014), a glucagon-like peptide-1 (GLP-1) receptor agonist studied in type 2 diabetes .
loading...
    loading...
Cat. No.: HY-P0014S2
Research Areas:  

Others

Liraglutide- 13C6, 15 TFA is the 13C and 15N labeledLiraglutide(HY-P0014). Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the study of type 2 diabetes mellitus .
loading...
    loading...
Cat. No.: HY-W099578
CAS No.: 204521-63-1
Synonyms: Palmitoyl-Glu(OSu)-OBut
Target:  

Drug Intermediate

Research Areas:  

Others

Pal-Glu(OSu)-OtBu (Palmitoyl-Glu(OSu)-OBut) is an important intermediate in the synthesis process of Liraglutide (HY-P0014) .
loading...
    loading...
Cat. No.: HY-P10985
CAS No.: 1627208-75-6
Target:  

Melanocortin Receptor

Research Areas:  

Metabolic Disease

CTX-1211 is a selective, orally effective melanocortin MC4R agonist (EC50=0.38 nM). CTX-1211 can enhance the feeding suppression and weight loss effects induced by liraglutide (HY-P0014), and promote anorexia and weight loss activity. CTX-1211 is mainly used in the study of obesity and other metabolic disorders .
loading...
    loading...
Cat. No.: HY-184966
CAS No.: 3059496-70-4
GIPR antagonist 4 is an orally active GIPR antagonist with an IC50 of 4.1 nM. GIPR antagonist 4 exerts its antagonistic effect by competitively binding to GIPR and blocking the increase in Gαs-mediated cAMP production induced by GIP agonists. The combination of GIPR antagonist 4 and Liraglutide (HY-P0014) can enhance the weight loss effect of the single drug. GIPR antagonist 4 can be used for research related to obesity and metabolic diseases .
loading...
    loading...
  • 1